Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Logynon tablets
0703010P0BBAAAA
|
Logynon | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | 4,287 |
|
TriRegol tablets
0703010P0BIAAAA
|
TriRegol | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,523 |
|
Logynon ED tablets
0703010P0BBABAE
|
Logynon | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | 796 |
|
Synphase tablets (Pfizer)
0703010P0BEAAAF
|
Synphase | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | 136 |
|
Generic Logynon tablets
0703010P0AAAAAA
|
Phased formulations of ethinylestradiol | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
|
Binovum tablets
0703010P0BDAAAB
|
Binovum | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Generic Binovum tablets
0703010P0AAABAB
|
Phased formulations of ethinylestradiol | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Generic Logynon ED tablets
0703010P0AAAEAE
|
Phased formulations of ethinylestradiol | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Generic Synphase tablets
0703010P0AAAFAF
|
Phased formulations of ethinylestradiol | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Generic Tri-Minulet tablets
0703010P0AAADAD
|
Phased formulations of ethinylestradiol | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Generic Trinovum tablets
0703010P0AAACAC
|
Phased formulations of ethinylestradiol | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Synphase tablets (Imported (Canada))
0703010P0BEABAF
|
Synphase | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Synphase tablets (Imported (Germany))
0703010P0BEACAF
|
Synphase | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Tri-Minulet tablets
0703010P0BGAAAD
|
Tri-Minulet | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Triadene tablets
0703010P0BHAAAD
|
Triadene | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Trinordiol tablets
0703010P0BCAAAA
|
Trinordiol | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Trinovum tablets
0703010P0BFAAAC
|
Trinovum | Phased formulations of ethinylestradiol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.